In the present study, we found that miR-101 was significantly downregulated in TMZ- resistant GBM cells, and its re-expression could reverse TMZ resistance through regulation of a serine/threonine protein kinase, glycogen synthase kinase 3β (GSK3β)[17, 18]. Here, GSK3B is linked to glioblastoma.